Variant · Snv
KIT M541L
CI-VAR-00002596Explore in graph →NP_000213.1:p.Met541LeuNM_000222.2:c.1621A>CClinVar 41599 CIViC 201 rs3822214
Curated evidence
Evidence by cancer (4 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25015329
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Chronic Leukemia1 | ||||||||
| KIT M541L | Imatinib | Predictive | C | Supports Sensitivity Response | 2 | accepted | EID1423In 5 patients with KIT M541L mutation-positive chronic eosinophilic leukemia (4 somatic and 1 germline mutation), treatment with low dose imatinib resulted in complete and lasting remission with a med… (full text at CIViC) PMID 25015329 · Iurlo et al., 2014 · Open in CIViC | civic |
| Chronic Myeloid Leukemia, BCR-ABL1 Positive1 | ||||||||
| KIT M541L | (diagnostic) | Diagnostic | B | Does Not Support Positive | 4 | accepted | EID485M541L mutation was not associated with CML in caucasian patients, and was common among healthy controls (8.1%), in contrast to a previous study in a Japanese CML patient population in which M541L was … (full text at CIViC) PMID 16307017 · | |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 41599 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Mastocytosis; Piebaldism; Gastrointestinal stromal tumor; Hereditary cancer-predisposing syndrome; Lip and oral cavity carcinoma | germline/somatic | 15 | Jun 04, 2026 | clinvar |